{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T01:01:32Z","timestamp":1784768492995,"version":"3.55.0"},"reference-count":0,"publisher":"Portico","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1358\/dot.2021.57.3.3251715","type":"journal-article","created":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T12:48:08Z","timestamp":1614948488000},"page":"209","source":"Crossref","is-referenced-by-count":8,"title":["Satralizumab: an interleukin-6 (IL-6) receptor antagonist for the\ntreatment of neuromyelitis optica spectrum disorders"],"prefix":"10.3730","volume":"57","author":[{"family":"Paton, D.M.","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1320","published-online":{"date-parts":[[2021]]},"container-title":["Drugs of Today"],"original-title":[],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T13:34:14Z","timestamp":1685453654000},"score":1,"resource":{"primary":{"URL":"http:\/\/access.portico.org\/stable?au=pjbf7dct5pj"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":0,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1358\/dot.2021.57.3.3251715","relation":{},"ISSN":["1699-4019"],"issn-type":[{"value":"1699-4019","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]}}}